How many benefit plans does Alnylam Pharmaceuticals, Inc. report on Form 5500?

Alnylam Pharmaceuticals, Inc. (EIN 04-3696884) reports 2 benefit plan(s) in the loaded Form 5500 dataset.

What is the EIN for Alnylam Pharmaceuticals, Inc.?

The Employer Identification Number (EIN) reported for Alnylam Pharmaceuticals, Inc. is 04-3696884.

What is the latest Form 5500 filing year for Alnylam Pharmaceuticals, Inc.?

The latest loaded Form 5500 filing year for Alnylam Pharmaceuticals, Inc. is 2023.

Alnylam Pharmaceuticals, Inc. — Form 5500 filings & benefit plans

Form 5500 plan sponsor summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Alnylam Pharmaceuticals, Inc. (EIN 04-3696884) is a plan sponsor located in Cambridge, MA with 2 reported benefit plan(s) in the loaded dataset. The latest loaded Form 5500 filing year is 2023.

Company overview (based on loaded 2023 public filings)

EIN: 04-3696884
Location: Cambridge, MA
Loaded plans: 2
Latest filing year: 2023

Reported financial aggregate (2023)

Reported net position

Total reported assets (EOY): $275,616,093
Total reported liabilities (EOY): $0
Total reported net assets (EOY): $275,616,093

Contributions & income

Employer contributions: $11,168,448
Participant contributions: $27,886,695
Total income / additions: $80,849,506

Expenses & distributions

Benefits paid / distributions: $15,182,936
Total expenses: $15,401,756
Net increase / (decrease): $65,447,750

Coverage

Total reported participants: 3,694
Plans with financial statements: 1
Plans with provider compensation: 1

Totals sum the latest loaded 2023 public Form 5500 filing per plan for this company's plans — one filing per plan, so multiple years are never double-counted. Figures are reported values from loaded Schedule H / I (and Schedule C for provider compensation); fields a plan did not report are treated as missing, not zero. These are not audited or official totals.

Largest loaded plans by reported assets

Alnylam Pharmaceuticals, Inc. plans by reported end-of-year assets
Plan	Plan #	Participants	Reported assets (EOY)	Year
Alnylam Pharmaceuticals, Inc. Savings & Investment Plan	001	2,090	$275,616,093	2023
Alnylam Pharmaceuticals, Inc. Consolidated Welfare Benefits Plan	501	1,604	not reported in the loaded dataset	2023

Search all 2 loaded plans for this company →

Latest loaded filings

Most recent loaded Form 5500 filings for Alnylam Pharmaceuticals, Inc.
Year	Plan	Participants	Schedules	Filing
2023	Alnylam Pharmaceuticals, Inc. Consolidated Welfare Benefits Plan	1,604	—	20240613173656NAL0014801107001
2023	Alnylam Pharmaceuticals, Inc. Savings & Investment Plan	2,090	H, C	20241010083758NAL0020698641001